Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysis.

Of note, the median time from diagnosis to second line treatment was six (3–19.5) months in the intolerance group versus 49 (9–100) months in the insufficient response group, but did not reach statistical significance (p-value 0.052).

also in 111,027 other papers